Benefícios do programa de navegação de pacientes e assistência de enfermagem em oncologia: revisão integrativa / Beneficios del programa de atención de enfermería de navegación y oncología del paciente: revisión integrativa / Benefits of the patient navigation and oncology nursing care program: integrative review

Objetivo: analisar pesquisas que adotaram como objeto os benefícios do programa navegação de pacientes e a assistência de enfermagem. Método: Trata-se de uma revisão integrativa utilizando a estratégia PICO (Paciente, Intervenção, Comparação e Desfecho). Bases de dados selecionadas: LILACS, Medline, IBECS, BDENF e SCIELO, entre 2015 e 2020. Descritores de busca: Enfermagem; Navegação de pacientes; Oncologia; Assistência. Resultados: Foram analisados 11 artigos, nos quais pode-se verificar que os benefícios relativos à inserção do programa de navegação de pacientes e da enfermagem dentro dos serviços de oncologia foram: reestruturação de ambos buscando a padronização e diretrizes; agilidade no tratamento; além do empoderamento da família/cliente no seguimento dos processos/tratamentos. Conclusões: No Brasil, há poucos estudos relacionados a implementação do programa de navegação a da assistência em enfermagem na oncologia. Porém, a literatura existente trouxe como promissores os benefícios ao cliente/família e à instituição, além da agilidade nos processos inerentes ao tratamento(AU)

Objective: to analyze research that adopted the benefits of the patient navigation program and nursing care as their object. Method: This is an integrative review using the PICO strategy (Patient, Intervention, Comparison and Outcome). Selected databases: LILACS, Medline, IBECS, BDENF and SCIELO, between 2015 and 2020. Search descriptors: Nursing; Patient navigation; Oncology; Assistance. Results: 11 articles were analyzed, in which it can be verified that the benefits related to the insertion of the navigation program for patients and nursing within the oncology services were: restructuring of both seeking standardization and guidelines; agility in treatment; in addition to the empowerment of the family/client in following the processes/treatments. Conclusions: In Brazil, there are few studies related to the implementation of the navigation program and nursing care in oncology. However, the existing literature brought as promising benefits to the client/family and the institution, in addition to the agility in the processes inherent to the treatment(AU)

Objetivo: analizar las investigaciones que adoptaron como objeto los beneficios del programa de navegación del paciente y los cuidados de enfermería. Método: Se trata de una revisión integradora que utiliza la estrategia PICO (Paciente, Intervención, Comparación y Resultado). Bases de datos seleccionadas: LILACS, Medline, IBECS, BDENF y SCIELO, entre 2015 y 2020. Descriptores de búsqueda: Enfermería; Navegación del paciente; Oncología; Asistencia. Resultados: Se analizaron 11 artículos, en los cuales se puede constatar que los beneficios relacionados con la inserción del programa de navegación para pacientes y enfermería dentro de los servicios de oncología fueron: reestructuración de ambos buscando estandarización y lineamientos; agilidad en el tratamiento; además del empoderamiento de la familia / cliente en el seguimiento de los procesos / tratamientos. Conclusiones: En Brasil, existen pocos estudios relacionados con la implementación del programa de navegación y cuidados de enfermería en oncología. Sin embargo, la literatura existente trajo como beneficios prometedores para el cliente / familia y la institución, además de la agilidad en los procesos inherentes al tratamiento.(AU)

Açaí (Euterpe oleracea Mart.) beverage consumption improves biomarkers for inflammation but not glucose- or lipid-metabolism in individuals with metabolic syndrome in a randomized, double-blinded, placebo-controlled clinical trial.

Açaí (Euterpe oleracea Mart.) berries, characterized by high polyphenol concentrations (predominantly anthocyanins), have demonstrated anti-inflammatory and anti-diabetic activities. The study objective was to determine the modulation of lipid and glucose-metabolism, as well as oxidative stress and inflammation, by an açaí-beverage (containing 1139 mg L-1 gallic acid equivalents of total polyphenolics) in 37 individuals with metabolic syndrome (BMI 33.5 ± 6.7 kg m-2) who were randomized to consume 325 mL twice per d of a placebo control or açaí-beverage for 12 weeks. Anthropometric measurements, dietary intake, and blood and urine samples were collected at baseline and after 12 weeks of consumption. Two functional biomarkers, plasma level of interferon gamma (IFN-γ) and urinary level of 8-isoprostane, were significantly decreased after 12 weeks of açaí consumption compared to the placebo control (p = 0.0141 and 0.0099, respectively). No significant modification of biomarkers for lipid- and glucose-metabolism was observed in this study. Findings from this small pilot study provide a weak indication that the selected dose of açaí polyphenols may be beneficial in metabolic syndrome as only two biomarkers for inflammation and oxidative stress were improved over 12 weeks. Follow-up studies should be conducted with higher polyphenol-doses before drawing conclusions regarding the efficacy of açaí polyphenols in metabolic syndrome.